Question 1

What specific monoclonal antibody treatment would I receive?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2 clinical trial (NCT05268601). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this treatment affect my chances of hospitalization?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2 clinical trial (NCT05268601). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the monoclonal antibodies?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2 clinical trial (NCT05268601). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during and after treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2 clinical trial (NCT05268601). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there other treatment options I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2 clinical trial (NCT05268601). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I do if my symptoms worsen?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2 clinical trial (NCT05268601). Contact the study team or your healthcare provider for specific answers.

What this study is about